The dynamics of the multiple myeloma market are anticipated to change in the coming years owing to the rise in novel drugs and therapies and the number of healthcare spending across the world. Key players, such as Janssen, Bristol Myers Squibb, Pfizer, Regeneron Pharmaceuticals, AbbVie,…